Yukie Kato
About Yukie Kato
Yukie Kato is a Senior Project Manager at Bristol Myers Squibb in Tokyo with extensive experience in the pharmaceutical industry, including roles at Sanofi Pasteur, CSL Behring, Ferring Pharmaceuticals, and Daiichi Sankyo.
Company
Yukie Kato is currently employed at Bristol Myers Squibb, a globally recognized biopharmaceutical company, where she holds the position of Senior Project Manager in 東京都. Bristol Myers Squibb is known for its focus on groundbreaking therapies in the realms of oncology, hematology, immunology, and cardiovascular disease.
Title
Yukie Kato serves as a Senior Project Manager at Bristol Myers Squibb. In this role, she is responsible for overseeing complex projects, ensuring they meet organizational and regulatory standards, and achieving key milestones in drug development and clinical research.
Work Experience at Sanofi Pasteur
Prior to her current role, Yukie Kato was part of Sanofi Pasteur, serving as R&D Project Manager in Tokyo from 2020 to 2021. Additionally, she held the position of Japan Project Head from 2019 to 2020. During her tenure at Sanofi Pasteur, she contributed to the development and management of innovative vaccine projects, leveraging her extensive experience in clinical research and project leadership.
Work Experience at CSL Behring
From 2015 to 2019, Yukie Kato worked as Japan Project Lead at CSL Behring in Tokyo. CSL Behring is renowned for its biopharmaceutical expertise, particularly in developing and delivering life-saving therapies. During her four-year tenure, she played a key role in managing major projects aimed at advancing therapeutic treatments in the Japanese market.
Educational Background
Yukie Kato has a robust educational background with multiple advanced degrees. She completed her Bachelor of Science in Pharmacy from Chiba University in 1993. She then pursued a Ph.D. in Orthopedic Surgery from the University of Toyama, graduating in 2004. Furthering her expertise, she obtained a Master of Business Administration (MBA) from Aoyama Gakuin University between 2008 and 2011. This academic foundation underpins her extensive knowledge in clinical research, drug development, and project management.